直肠癌切除术后放疗与继发恶性肿瘤风险的倾向性调整人群分析
基于SEER登记1973-2012年77,484例直肠腺癌切除患者,比较放疗与未放疗者继发恶性肿瘤风险。放疗整体未增加继发肿瘤风险(HR=0.97),但前列腺癌风险降低,子宫内膜癌、肺癌、膀胱癌及淋巴瘤风险升高。
要点
- 放疗整体未显著增加继发恶性肿瘤风险(HR=0.97,95%CI 0.92-1.02,P=0.269)。
- 放疗与前列腺癌风险降低相关(HR=0.42,95%CI 0.36-0.48,P<0.001)。
- 放疗与子宫内膜癌、肺癌、膀胱癌及淋巴瘤风险升高相关。
核心结论
- 直肠癌放疗整体未显著增加继发恶性肿瘤风险,但特定部位风险有升有降。
研究设计与样本
- 基于SEER登记的人群回顾性队列,纳入1973-2012年确诊的77,484例局限或局部晚期直肠腺癌切除患者。
- 采用分层及倾向性评分匹配的Cox回归分析比较放疗与未放疗者的继发恶性肿瘤风险。
主要发现
- 77,484例中34,114例接受放疗,43,370例未接受放疗。
- 放疗与前列腺癌风险降低相关(HR=0.42,95%CI 0.36-0.48,P<0.001)。
- 放疗与子宫内膜癌风险升高相关(HR=1.95,95%CI 1.49-2.56,P<0.001)。
- 放疗与肺癌风险升高相关(HR=1.18,95%CI 1.06-1.30,P<0.001)。
- 放疗与膀胱癌(HR=1.54,95%CI 1.31-1.80,P<0.001)及淋巴瘤(HR=1.27,95%CI 1.03-1.58,P=0.026)风险升高相关。
临床怎么用
- 直肠癌放疗决策时应权衡特定继发恶性肿瘤风险,尤其关注子宫内膜癌、肺癌、膀胱癌及淋巴瘤。
- 前列腺癌风险降低的机制及临床意义需进一步研究,不应作为放疗指征。
局限性
- 为回顾性SEER登记分析,可能存在未测量混杂因素。
- 继发恶性肿瘤定义为直肠癌诊断后至少1年发生,中位随访5.8年(范围1-39.9年)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The relationship between radiation therapy for rectal cancer and secondary malignancies is debated. The present study is the first population-based analysis using conventional multivariable analyses as well as propensity score matching to assess this relationship. METHODS: Overall, 77,484 patients after resection of localized or locally advanced rectal adenocarcinoma diagnosed between 1973 and 2012 were identified in the Surveillance, Epidemiology, and End Results (SEER) registry. The occurrence of secondary malignancies diagnosed at least 1 (median follow up 5.8years [1-39.9years]) year after rectal cancer diagnosis was compared in patients who did and did not undergo radiation using stratified and propensity score matched Cox regression analysis. RESULTS: Of 77,484 patients, 34,114 underwent radiation and 43,370 did not. Ignoring gender and entity, radiation therapy was not associated with secondary malignancies (hazard ratio [HR]=0.97 (95%CI: 0.92-1.02, P=0.269). The risk for prostate cancer was decreased and (HR=0.42, 95%CI: 0.36-0.48, P<0.001) and increased risk for endometrial cancer (HR=1.95, 95%CI: 1.49-2.56, P<0.001). Overall, patients undergoing radiation had higher risks for lung cancer (HR=1.18, 95%CI: 1.06-1.30, P<0.001), bladder cancer (HR=1.54, 95%CI: 1.31-1.80, P<0.001) and lymphomas (HR=1.27, 95%CI: 1.03-1.58, P=0.026). CONCLUSIONS: The present analysis describes the occurence of secondary malignancies after pelvic radiation in patients undergoing rectal cancer surgery. Indeed, radiation for rectal cancer is associated with a significantly decreased risk of prostate cancer, however, an increased risk of endometrial, lung, and bladder cancer as well as lymphomas was observed. Overall, the risk of secondary malignancies was slightly decreased with radiation in patients undergoing rectal cancer resection, this was attributable to lower rates in prostate cancer.
引用
- Warschkow R, Güller U, Cerny T, et al. Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis. Radiother Oncol. 2017. PMID: 28285840. doi:10.1016/j.radonc.2017.02.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。